Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 15/20 | 0.38 |
| ▸ | THRA | P10827 | 1/20 | 0.34 |
| ▸ | VDR | P11473 | 1/20 | 0.34 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10180803 | 0.87 | STAT3 (0.36) | STAT3THRAVDRPRMT5 | |
| SCHEMBL10181103 | 0.86 | PRMT5 (0.34) | STAT3THRAVDRPRMT5 | |
| SCHEMBL10180156 | 0.84 | STAT3 (0.35) | STAT3PRMT5EGLN1 | |
| SCHEMBL10187805 | 0.83 | STAT3 (0.36) | STAT3PRMT5 | |
| SCHEMBL10179807 | 0.82 | GPR119 (0.35) | STAT3THRAVDRPRMT5 | |
| SCHEMBL10179385 | 0.81 | PRMT5 (0.36) | THRAVDRPRMT5 | |
| SCHEMBL10179406 | 0.79 | EGLN1 (0.35) | STAT3PRMT5EGLN1 | |
| SCHEMBL10180322 | 0.78 | PRMT5 (0.35) | STAT3THRAVDRPRMT5EGLN1 | |
| SCHEMBL10180215 | 0.78 | HRH3 (0.35) | THRAVDRPRMT5EGLN1 | |
| SCHEMBL10181903 | 0.78 | FASN (0.35) | STAT3THRAPRMT5EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120245344-A1 | GPR119 AGONIST | NIPPON CHEMIPHAR CO., LTD. (JP) | 2012-09-27 | — | — | US | disclosed |
| EP-2474540-A1 | GPR119 AGONIST | Nippon Chemiphar Co., Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120245344-A1 | GPR119 AGONIST | GPR119, GPR4, GPR55 | STAT3 1743/4885THRA 413/4885VDR 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.